课题基金 / 基金详情

BIOCHEMISTRY OF SCRAPIE PATHOGENESIS

BIOCHEMISTRY OF SCRAPIE PATHOGENESIS
痒病发病机制的生物化学
批准号:
6288884
负责人:
BYRON CAUGHEY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

BYRON CAUGHEY的其他基金

相关文献

中文摘要
翻译
传染性海绵状脑病(TSE或朊病毒病)是致命的神经退行性疾病,如羊瘙痒病、克雅氏病(CJD)、疯牛病和慢性消耗性疾病(CWD)。我们的项目旨在了解和阻止PrP-res的积累,PrP-res是朊病毒蛋白(PrP)的异常形式,似乎是TSE传播和发病机制的基础。使用细胞培养和无细胞系统,我们已经1)鉴定了四吡咯作为一类新的PrP-res形成抑制剂,2)证明了PrP中需要完整的二硫键才能转化为PrP-res,3)证明了PrP-res的不同构象与仓鼠中不同的TSE菌株相关,4)分析了刚果红的结构-功能方面,一种已知的PrP-res形成抑制剂,5)开发了一种新的无细胞测定法,用于监测PrP-res和正常PrP之间的结合相互作用,所述结合相互作用导致后者转化为前者,和6)评估了来自感染CWD的鹿和麋鹿的PrP-res诱导来自人的正常PrP转化的能力,牛和其他物种的PrP-res. -传染性海绵状脑病、朊病毒、神经变性、慢性消耗性疾病、羊瘙痒病、克雅氏病
英文摘要
Transmissible spongiform encephalopathies (TSEs or prion disease) are fatal neurodegenerative diseases such as scrapie, Creutzfeldt-Jakob disease (CJD), BSE and chronic wasting disease (CWD). Our project is aimed at understanding and thwarting the accumulation of PrP-res, the abnormal form of prion protein (PrP) that appears to underlie TSE transmission and pathogenesis. Using cell culture and cell-free systems we have 1) identified tetrapyrroles as a new class of inhibitors of PrP-res formation, 2) demonstrated a need for an intact disulfide bond in PrP for its conversion to PrP-res, 3) demonstrated that different conformations of PrP-res are associated with different TSE strains in hamsters, 4) analyzed the structure-function aspects of Congo red, a known inhibitor of PrP-res formation, 5) developed a new cell-free assay for monitoring the binding interactions between PrP-res and normal PrP that lead to conversion of the latter into the former and 6) assessed the ability of PrP-res from CWD-infected deer and elk to induce the conversion of normal PrP from humans, cattle and other species to PrP-res. - Transmissible spongiform encephalopathies, prions, neurodegeneration, chronic wasting disease, scrapie, Creutzfeldt-Jakob disease
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prion Disease Therapeutics
Structures and Activities of Prions and Prion Proteins
Prion Disease Therapeutics
Detection of Prions